EAnnatto
EAnnatto, licence 80090692: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- UV International Traders Inc (DBA Wellnessextract)
- NPN or DIN-HM
- 80090692
- Status
- Active licence
- Licence date
- 18 February 2019
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| tocotriénols Source : Bixa orellana - Graine Potency : 90.0 % delta-Tocotrienol | 125.0 milligramme | Not calculated |
| tocotriénols Source : Bixa orellana - Graine Potency : 10.0 % gamma-Tocotrienol | Not specified | Not calculated |
Non-medicinal ingredients
Eau, Gélatine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Source of/An antioxidant that helps protect (cell) against (cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use.
- Effets indésirables connus
Allergic reaction has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Keep out of the reach of children. If you are taking any prescription medication, consult a health care practitioner prior to use. If you have increased risk of bleeding due to clotting disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80090692
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.